Marta Mikos is an Analyst at First Analysis, focusing on pharma IT. She co-authored a report on key themes in pharma IT investment and transaction activity.
At firms with a similar stage, sector and check size.
One email when Marta's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMarta Mikos is an Analyst at First Analysis, focusing on pharma IT. She co-authored a report on key themes in pharma IT investment and transaction activity.
Marta Mikos invests through First Analysis, which writes checks of $3M to $10M at series a, series b.
A warm intro from a founder First Analysis backed works best. A short LinkedIn note with one line on traction is the next best route.
Last updated 2026-10-15. Is this you? Ask for a correction.